C. Ann Merrifield - Nov 17, 2022 Form 4 Insider Report for INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVIV	Stock Option (right to buy)	Award	$0	+4.2K		$0.00	4.2K	Nov 17, 2022	Common Stock	4.2K	$2.50	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option was granted on November 17, 2022. 100% of the shares shall vest on November 17, 2023.